Ipamorelin: Complete Research Guide & Chemical Profile

Ipamorelin is a synthetic pentapeptide belonging to the growth hormone releasing peptide (GHRP) family. Originally developed by Novo Nordisk and assigned the research designation NNC 26-0161, this compound functions as a selective growth hormone secretagogue with unique receptor binding characteristics.

The peptide features a molecular weight of 711.85 g/mol and follows the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. This specific sequence incorporates modified amino acids including aminoisobutyric acid (Aib) at the N-terminus and D-configured amino acids that enhance stability and receptor selectivity.

What distinguishes Ipamorelin from other growth hormone releasing peptides is its selective activity profile. Research indicates that unlike GHRP-6 or GHRP-2, Ipamorelin demonstrates minimal stimulation of ACTH and cortisol release while maintaining potent growth hormone secretagogue activity.

Initial research on Ipamorelin began in the late 1990s when Novo Nordisk scientists sought to develop a more selective growth hormone releasing compound. Early preclinical studies demonstrated that Ipamorelin could stimulate growth hormone release with reduced side effects compared to existing GHRPs.

A pivotal study published in the European Journal of Endocrinology examined Ipamorelin's effects in healthy male volunteers. Researchers found that intravenous administration resulted in dose-dependent growth hormone release with minimal impact on cortisol or prolactin levels, confirming the compound's selectivity profile.

Subsequent research has explored Ipamorelin's potential applications in various laboratory models. Studies investigating bone density, muscle mass preservation, and metabolic parameters have provided insights into the compound's broader physiological effects beyond growth hormone stimulation.

Recent investigations have focused on Ipamorelin's pharmacokinetic properties, revealing a plasma half-life of approximately 2 hours in human subjects. This relatively short duration has implications for research protocol design and dosing frequency considerations in laboratory studies.

Ipamorelin exerts its biological effects through selective binding to the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHSR). This G-protein coupled receptor is primarily located in the anterior pituitary gland and hypothalamus, where it mediates growth hormone release.

The structural modifications in Ipamorelin's amino acid sequence contribute to its high selectivity for the ghrelin receptor. The D-2-naphthylalanine and D-phenylalanine residues provide conformational rigidity that enhances binding affinity while reducing off-target interactions with other receptor systems.

Research suggests that Ipamorelin's binding affinity for the ghrelin receptor is comparable to natural ghrelin, yet it demonstrates significantly reduced activity at other receptors that mediate ACTH and cortisol release. This selectivity profile makes it a valuable research tool for studying growth hormone pathways.

Upon binding to the ghrelin receptor, Ipamorelin activates intracellular signaling cascades involving phospholipase C and protein kinase C. This activation leads to increased intracellular calcium levels in somatotroph cells, triggering the exocytosis of growth hormone-containing vesicles.

The compound's mechanism also involves modulation of somatostatin release, which normally inhibits growth hormone secretion. Studies indicate that Ipamorelin may reduce somatostatin's inhibitory effects, creating a more favorable environment for sustained growth hormone release.

Ipamorelin presents as a white to off-white lyophilized powder when supplied in research-grade form. The compound's chemical stability and handling characteristics are important considerations for laboratory applications and storage protocols.

Research-grade Ipamorelin typically maintains purity standards of ≥99.0% as determined by high-performance liquid chromatography (HPLC) analysis. This high purity level ensures consistent results in research applications and minimizes potential interference from impurities.

Proper storage conditions are critical for maintaining Ipamorelin's stability and activity. The lyophilized form should be stored at -20°C in a dry environment, protected from light and moisture. Once reconstituted in sterile water or appropriate buffer solutions, the peptide should be used promptly or stored at 2-8°C for short-term use.

Ipamorelin demonstrates good solubility in water and physiological buffer solutions, facilitating its use in various research applications. The peptide remains stable in aqueous solutions for several days when stored under appropriate refrigerated conditions.

Temperature sensitivity studies indicate that Ipamorelin maintains structural integrity at physiological temperatures for extended periods, making it suitable for in vitro cell culture experiments and other laboratory assays requiring stable peptide concentrations.

Researchers seeking high-quality Ipamorelin for laboratory studies can access verified suppliers through ChemVerify's comprehensive vendor database. The platform provides detailed information about third-party tested batches, purity certificates, and supplier verification status.

ChemVerify's Ipamorelin product page at /product/ipamorelin offers researchers access to comparative analysis of different suppliers, pricing information, and user reviews from the research community. This centralized resource helps ensure researchers obtain authentic, high-purity compounds for their studies.

The platform's verification process includes review of certificates of analysis, supplier credentials, and ongoing quality monitoring to maintain the highest standards for research peptide sourcing.

**What makes Ipamorelin different from other GHRPs in research applications?**

Ipamorelin's primary advantage in research settings is its selective activity profile. Unlike GHRP-6 or GHRP-2, studies show that Ipamorelin stimulates growth hormone release without significantly affecting cortisol or ACTH levels, making it ideal for studying isolated growth hormone pathways.

**How should Ipamorelin be reconstituted for laboratory use?**

Research protocols typically involve reconstituting lyophilized Ipamorelin with sterile water or bacteriostatic water. The reconstituted solution should be gently mixed to avoid foam formation and used according to specific experimental requirements. Always follow institutional laboratory safety guidelines.

**What is the typical half-life of Ipamorelin in research models?**

Studies indicate that Ipamorelin has a plasma half-life of approximately 2 hours in human subjects. This relatively short duration affects experimental design considerations, particularly for studies examining sustained effects or requiring multiple sampling timepoints.

**Can Ipamorelin be used in cell culture experiments?**

Yes, Ipamorelin's stability in aqueous solutions makes it suitable for in vitro cell culture applications. Researchers studying ghrelin receptor signaling or growth hormone-related pathways in cellular models commonly use Ipamorelin as a selective agonist in their experimental protocols.

**What analytical methods are used to verify Ipamorelin purity?**

High-performance liquid chromatography (HPLC) is the standard analytical method for determining Ipamorelin purity. Additional verification may include mass spectrometry for molecular weight confirmation and amino acid analysis to verify sequence integrity in research-grade preparations.

**How does Ipamorelin's selectivity benefit research outcomes?**

The selective nature of Ipamorelin allows researchers to study growth hormone-related effects without confounding variables from cortisol or ACTH stimulation. This selectivity provides cleaner experimental data and helps isolate specific physiological pathways in research models.

Explore detailed chemical profiles and research guides for compounds discussed in this article:

• GHRP-6: Complete Research Guide → /learn/ghrp-6-research-guide-chemical-profile

• Read more: RFK Jr. Signals Reversal of Peptide Ban: 14 of 19 Restricted Compounds May Return → https://www.chemverify.com/learn/rfk-jr-signals-reversal-of-peptide-ban-14-of-19-restricted-compounds-may-return
• Read more: Beyond Sleep: Complete Research Guide & Chemical Profile → https://www.chemverify.com/learn/beyond-sleep
• Read more: CJC-1295 (No DAC): Complete Research Guide & Chemical Profile → https://www.chemverify.com/learn/cjc-1295
• Read more: IGF-1 LR3: Complete Research Guide & Chemical Profile → https://www.chemverify.com/learn/igf-1-lr3
• Read more: Tesamorelin: Complete Research Guide & Chemical Profile → https://www.chemverify.com/learn/tesamorelin